02 July 2004
Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins
Luminita Radulescu, Camelia Stancu, Felicia AntoheMed Sci Monit 2004; 10(7): BR207-214 :: ID: 11707
Abstract
Background:Recently there has been much interest in the significance and role of antibodies to oxidized LDL (oxLDL) in the plasma of humans and animals with evolving atherosclerosis. The focus in our study was directed on the significance of these antibodies for the pathogenesis and diagnosis of atherosclerosis.
Material/Methods:Antibodies to human in vitro oxidized LDL were generated following the method of Kohler & Milstein and used to detect oxidized LDL in human plasma.Results:Several antibodies to oxLDL were selected for high reactivity against circulating modified LDL. The relationship between antibodies against oxLDL and circulating oxLDL level in human plasma was examined in normal and hyperlipidemic patients. The slight inverse relationship observed between anti-oxLDL antibodies and oxLDL levels in normal patients suggests that anti-oxLDL antibodies have a role in the clearance of oxLDL from circulation.Conclusions:These antibodies can be considered as markers of the pathogenic determinants of atherosclerosis, such as enhanced lipid oxidation, pro-inflammatory stage, and impaired vasodilatation.
Keywords: Angina Pectoris - blood, Antibodies, Monoclonal - chemistry, Antibodies, Monoclonal - immunology, Apolipoprotein A-I - blood, Apolipoproteins B - blood, Autoantibodies - blood, Biological Markers - blood, Blood Glucose - metabolism, Cholesterol - blood, Enzyme-Linked Immunosorbent Assay, Hypertension - blood, Lipoproteins - blood, Lipoproteins, LDL - blood, Lipoproteins, LDL - immunology, Myocardial Ischemia - blood, Spleen - cytology, Triglycerides - blood, Angina Pectoris - blood, Antibodies, Monoclonal - immunology, Apolipoprotein A-I - blood, Apolipoproteins B - blood, Autoantibodies - blood, Biological Markers - blood, Blood Glucose - metabolism, Cholesterol - blood, Enzyme-Linked Immunosorbent Assay, Hypertension - blood, Lipoproteins - blood, Lipoproteins, LDL - immunology, Myocardial Ischemia - blood, Spleen - cytology, Triglycerides - blood
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952